— Know what they know.
Not Investment Advice
Also trades as: KURN.SW (SIX) · $vol 4M · 0RHR.L (LSE) · $vol 0M

CSBTF OTC

Kuros Biosciences AG
1W: +0.0% 1M: -11.1% 3M: +5.6% YTD: -37.4% 1Y: -15.2% 3Y: +1150.0% 5Y: +879.6%
$24.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 37 · $946.5M mcap · 28M float · 0.0011% daily turnover · Short 98% of daily vol

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
Oct 02, 2026
DCF
1
ROE
3
ROA
5
D/E
2
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CSBTF receives an overall rating of C+. Strongest factors: ROA (5/5). Areas of concern: DCF (1/5), D/E (2/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-03 None ADDED
2026-09-30 EXISTED None
2026-09-26 None ADDED
2026-09-26 EXISTED None
2026-09-22 None ADDED
2026-09-19 EXISTED None
2026-09-15 None ADDED
2026-09-14 EXISTED None
2026-09-01 None ADDED
2026-08-30 EXISTED None

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade D
Profitability
31
Balance Sheet
67
Earnings Quality
57
Growth
75
Value
—
Momentum
70
Safety
—
Cash Flow
16

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
4/9
✓ ✓ ✓ ✗ ✗ ✗ ✗ ✗ ✓
Beneish M-Score
-0.66
Possible Manipulator
Ohlson O-Score
-7.38
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB
Score: 57.4/100
Trend: Improving
Earnings Quality
25/100
OCF/NI: 0.32x
Accruals: 1.1%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CSBTF scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CSBTF's score of -0.66 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CSBTF's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CSBTF receives an estimated rating of BBB (score: 57.4/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CSBTF's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
102.93x
PEG
0.12x
P/S
5.30x
P/B
10.21x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$1.28
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 102.9x earnings, CSBTF is priced for high growth expectations. Graham's intrinsic value formula yields $1.28 per share, 1777% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.377
NI / EBT
×
Interest Burden
0.457
EBT / EBIT
×
EBIT Margin
0.037
EBIT / Rev
×
Asset Turnover
2.496
Rev / Assets
×
Equity Multiplier
1.493
Assets / Equity
=
ROE
2.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CSBTF's ROE of 2.4% is driven by Asset Turnover (2.496), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.38 suggests the company retains less than 60% of pre-tax earnings after taxes.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$0.34
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CSBTF's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CSBTF trades at a premium to its adjusted intrinsic value of $0.34, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 102.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$24.00
Median 1Y
$16.09
5th Pctile
$2.52
95th Pctile
$105.84
Ann. Volatility
119.1%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
ROE -4.2% -78.6% -98.2% -50.6% -49.1% -35.5% -30.4% -33.4% -28.3% -22.6% -24.6% -23.3% -28.8% -36.4% -42.4% -37.2% -27.3% -20.5% -3.4% 2.4% 2.40%
ROA -83.2% -66.2% -81.1% -44.2% -43.5% -30.7% -26.4% -29.5% -25.3% -20.2% -21.3% -20.0% -25.0% -31.5% -34.8% -30.0% -20.8% -15.3% -2.3% 1.6% 1.61%
ROIC -77.8% -44.1% -52.6% -39.4% -40.7% -36.7% -33.8% -34.7% -31.9% -25.9% -32.8% -25.0% -32.4% -35.2% -41.6% -35.6% -33.6% -13.2% -15.6% 3.5% 3.54%
ROCE -63.1% -36.5% -46.2% -38.8% -36.6% -33.0% -23.1% -21.6% -12.8% -10.7% -12.8% -11.0% -13.2% -16.4% -19.4% -16.4% -15.1% -4.6% 6.2% 11.0% 10.95%
Gross Margin -448.0% 1.0% — 94.2% 81.9% -65.9% -2.1% -15.7% -29.0% 75.8% 56.9% 78.7% 74.6% 80.5% 84.2% 89.1% 77.0% 88.7% 85.4% 85.2% 85.21%
Operating Margin -1240.5% -13.0% — -21.1% -18.0% -6.1% -3.7% -5.0% -2.0% -17.2% -1.6% -23.9% -1.0% -36.2% -41.9% -1.8% -10.1% 5.5% 6.4% 5.6% 5.61%
Net Margin -1081.5% -13.1% — -19.1% -14.6% -5.7% -3.6% -4.5% -2.1% -1.1% -1.6% -35.5% -1.4% -39.3% -41.9% -0.7% -8.0% -3.2% 5.5% 4.8% 4.77%
EBITDA Margin -1181.2% -12.0% — -18.4% -15.3% -1.4% -1.0% -1.4% -50.5% 7.9% -47.0% 2.2% -30.7% -6.6% -14.9% 1.2% -2.2% 7.1% 8.7% 8.0% 8.03%
FCF Margin -9.6% -9.4% -12.6% -28.4% -19.3% -15.5% -7.3% -5.3% -3.1% -1.0% -85.6% -61.6% -42.7% -54.5% -32.8% -15.0% -6.5% -2.5% -0.4% -3.0% -3.00%
OCF Margin -9.5% -9.2% -12.3% -27.7% -18.8% -15.2% -7.2% -5.2% -3.0% -98.2% -82.3% -59.8% -40.3% -52.7% -31.4% -13.3% -5.2% -1.0% 1.2% 0.2% 0.20%
ROE 3Y Avg snapshot only -20.73%
ROE 5Y Avg snapshot only -27.18%
ROA 3Y Avg snapshot only -16.66%
ROIC 3Y Avg snapshot only -7.37%
ROIC Economic snapshot only 3.41%
Cash ROA snapshot only 0.42%
Cash ROIC snapshot only 0.67%
CROIC snapshot only -9.87%
NOPAT Margin snapshot only 1.08%
Pretax Margin snapshot only 1.71%
R&D / Revenue snapshot only 7.50%
SGA / Revenue snapshot only 66.50%
SBC / Revenue snapshot only 2.01%
Valuation
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — 102.928
P/S Ratio — — — — — — — — — — — — — — — — — — — — 5.297
P/B Ratio — — — — — — — — — — — — — — — — — — — — 10.210
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
PEG Ratio snapshot only 0.120
Graham Number snapshot only $1.28
Leverage & Solvency
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Current Ratio 4.10 4.87 3.80 3.67 4.91 4.63 6.40 5.73 8.76 8.43 2.91 2.43 2.49 2.26 2.06 2.73 2.14 2.25 1.96 1.87 1.871
Quick Ratio 4.02 4.84 3.75 3.53 4.77 4.42 6.14 5.34 8.39 8.06 2.76 2.25 2.24 1.89 1.69 2.17 1.69 1.74 1.45 1.28 1.278
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.04 0.03 0.04 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.03 0.03 0.02 0.06 0.15 0.153
Net Debt/Equity -0.32 -0.28 -0.23 -0.14 -0.24 -0.14 -0.24 -0.18 -0.31 -0.29 -0.34 -0.27 -0.32 -0.22 -0.21 -0.20 -0.27 -0.21 -0.18 0.04 0.044
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.04 0.03 0.03 0.02 0.03 0.02 0.02 0.02 0.04 0.03 0.03 0.02 0.02 0.04 0.09 0.092
Debt/EBITDA -0.00 -0.00 -0.00 -0.00 -0.00 -0.14 -0.16 -0.22 -0.38 -0.57 -0.45 -0.73 -0.53 -0.56 -0.36 -0.33 -0.40 2.17 0.41 0.73 0.728
Net Debt/EBITDA 0.50 0.71 0.47 0.35 0.68 0.44 1.25 1.10 4.20 5.93 5.60 7.39 6.17 2.71 2.00 2.10 3.48 -19.56 -1.22 0.21 0.209
Interest Coverage — — — — — — — — — — — — -9.65 -5.41 -2.31 -1.85 -2.35 -0.60 1.02 2.03 2.029
Equity Multiplier 1.14 1.17 1.18 1.15 1.12 1.14 1.13 1.12 1.12 1.10 1.19 1.21 1.20 1.22 1.26 1.28 1.44 1.43 1.60 1.67 1.669
Cash Ratio snapshot only 0.219
Debt Service Coverage snapshot only 3.326
Cash to Debt snapshot only 0.713
FCF to Debt snapshot only -0.674
Defensive Interval snapshot only 79.1 days
Efficiency & Turnover
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Asset Turnover 0.04 0.04 0.04 0.01 0.02 0.02 0.04 0.05 0.07 0.17 0.20 0.32 0.36 0.41 0.63 0.88 1.30 1.70 2.30 2.50 2.496
Inventory Turnover 61.04 113.36 112.54 34.44 11.10 14.98 5.61 5.80 8.20 8.73 6.84 5.59 3.62 3.01 3.00 2.43 3.06 2.65 2.79 2.68 2.683
Receivables Turnover 7.82 6.18 18.99 7.94 4.79 2.74 7.18 14.49 10.56 12.26 14.57 6.87 16.51 11.98 12.73 8.85 13.46 12.32 13.51 15.73 15.727
Payables Turnover 11.82 9.80 12.58 6.88 3.17 5.39 2.77 6.82 6.46 14.00 9.73 14.17 7.48 9.71 9.24 5.96 4.70 5.91 4.96 5.21 5.213
DSO 47 59 19 46 76 133 51 25 35 30 25 53 22 30 29 41 27 30 27 23 23.2 days
DIO 6 3 3 11 33 24 65 63 44 42 53 65 101 121 122 150 119 138 131 136 136.0 days
DPO 31 37 29 53 115 68 132 54 56 26 37 26 49 38 40 61 78 62 74 70 70.0 days
Cash Conversion Cycle 22 25 -7 4 -6 90 -16 35 23 46 41 93 74 114 111 130 69 106 84 89 89.2 days
Fixed Asset Turnover snapshot only 15.767
Operating Cycle snapshot only 159.2 days
Cash Velocity snapshot only 31.450
Capital Intensity snapshot only 0.487
Growth (YoY)
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Revenue 20.5% 65.9% 39.4% -52.1% 3.7% -4.9% 1.1% 4.3% 4.3% 8.1% 4.4% 5.3% 3.8% 1.4% 1.9% 1.7% 2.4% 3.5% 3.0% 2.4% 2.36%
Net Income 25.0% 12.5% 9.0% 21.7% -10.4% 14.8% 36.7% 16.6% 19.2% 33.2% 16.9% 28.1% 2.8% -53.5% -48.6% -46.7% 21.2% 46.8% 92.7% 1.1% 1.06%
EPS 94.8% 77.9% 67.5% 53.5% 38.7% 69.7% 72.2% 71.5% 72.3% 64.1% 54.4% 46.6% 24.6% -37.8% -33.1% -30.5% 27.4% 51.7% 93.3% 1.1% 1.06%
FCF 51.4% 34.6% 23.6% -26.4% -1.1% -56.5% -18.4% 2.2% 15.3% 40.3% 36.0% 26.6% 33.5% -28.8% -10.7% 34.2% 47.4% 79.1% 95.3% 32.6% 32.57%
EBITDA -32.1% -51.6% -55.2% -0.7% -8.6% 27.4% 58.6% 57.5% 76.9% 80.8% 68.0% 77.0% 42.1% -23.4% -27.6% -1.2% -25.4% 1.2% 2.6% 3.6% 3.56%
Op. Income -35.0% -56.8% -62.3% -6.8% -17.2% 9.0% 32.4% 11.4% 21.1% 31.1% 17.5% 35.0% 18.9% -13.1% -12.2% -27.2% 4.5% 54.4% 1.1% 1.3% 1.34%
OCF Growth snapshot only 1.05%
Asset Growth snapshot only 54.55%
Equity Growth snapshot only 18.98%
Debt Growth snapshot only 4.57%
Shares Change snapshot only 6.96%
Growth (CAGR)
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Revenue 3Y — — — — — — — 1.0% 87.6% 1.4% 1.5% 1.5% 2.0% 1.8% 2.2% 3.5% 3.4% 3.6% 3.0% 2.9% 2.85%
Revenue 5Y — — — — — — — — — — — — — — — 1.7% 1.6% 1.7% 1.8% 1.7% 1.70%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — 60.9% 74.9% 2.2% 2.0% 22.0% 23.8% -4.9% -6.0% -0.7% -0.5% 10.7% 6.9% 13.9% 13.91%
Assets 5Y — — — — — — — — — — — — — — — 31.9% 36.8% 1.1% 1.0% 19.7% 19.68%
Equity 3Y — — — — — — — — — 3.0% 3.9% 19.5% 21.6% -6.3% -8.1% -4.3% -8.4% 2.5% -4.9% -0.2% -0.23%
Book Value 3Y — — — — — — — — — 46.0% 1.1% -36.4% -35.7% -47.9% -44.9% -41.7% -42.7% -22.1% -27.2% -15.0% -15.04%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Revenue Stability — — — 0.06 0.88 0.65 0.90 0.62 0.64 0.63 0.70 0.68 0.74 0.86 0.84 0.65 0.61 0.58 0.60 0.63 0.634
Earnings Stability — — — 0.34 0.45 1.00 0.90 0.04 0.70 0.97 0.94 0.06 0.75 0.52 0.53 0.03 0.85 0.71 0.73 0.73 0.727
Margin Stability — — — 0.74 0.46 0.36 0.12 0.29 0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.50 0.50 0.50 0.00 1.00 0.00 1.00 0.50 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.50 0.50 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — 0.91 0.96 0.94 0.85 0.93 0.92 0.87 0.93 0.89 0.99 0.50 0.81 0.81 0.92 0.81 0.50 0.20 0.200
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — 13.24 29.71 0.30 0.25 0.18 0.15 0.14 -0.00 -0.13 -0.23 -0.13 -0.00 0.13 0.34 0.34 0.344
Gross Margin Trend — — — -0.60 4.89 3.66 7.52 6.47 4.08 3.69 3.86 4.60 2.19 1.93 0.57 0.59 0.58 0.27 0.21 0.11 0.109
FCF Margin Trend — — — -11.15 -2.63 1.16 10.56 14.33 11.35 11.44 9.11 16.23 10.77 7.71 3.74 2.79 1.70 0.76 0.59 0.35 0.353
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — 2.4% 2.40%
Internal Growth Rate — — — — — — — — — — — — — — — — — — — 1.6% 1.63%
Cash Flow Quality
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
OCF/Net Income 0.45 0.51 0.54 0.80 0.83 0.94 1.03 0.95 0.88 0.82 0.77 0.95 0.58 0.69 0.57 0.39 0.33 0.11 -1.16 0.32 0.316
FCF/OCF 1.00 1.02 1.03 1.03 1.03 1.02 1.01 1.01 1.02 1.04 1.04 1.03 1.06 1.03 1.04 1.13 1.25 2.48 -0.33 -14.76 -14.760
FCF/Net Income snapshot only -4.666
OCF/EBITDA snapshot only 0.033
CapEx/Revenue 4.1% 17.3% 36.7% 71.6% 48.0% 24.4% 5.6% 7.2% 5.1% 3.6% 3.3% 1.8% 2.4% 1.8% 1.4% 1.7% 1.3% 1.5% 1.6% 3.2% 3.21%
CapEx/Depreciation snapshot only 1.342
Accruals Ratio -0.46 -0.33 -0.37 -0.09 -0.07 -0.02 0.01 -0.02 -0.03 -0.04 -0.05 -0.01 -0.11 -0.10 -0.15 -0.18 -0.14 -0.14 -0.05 0.01 0.011
Sloan Accruals snapshot only 0.042
Cash Flow Adequacy snapshot only 0.063
Earnings Quality Score snapshot only 0.250
Dividends & Buybacks
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — 0.0% 0.00%
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — 0.0% 0.00%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Tax Burden (NI/EBT) 0.98 0.98 0.98 0.95 0.93 0.92 0.90 0.89 0.95 0.91 0.88 0.95 1.22 1.23 1.28 1.36 1.04 1.23 -2.99 0.38 0.377
Interest Burden (EBT/EBIT) 1.02 1.01 0.98 1.00 1.01 1.12 1.32 1.57 2.06 2.01 2.10 2.14 1.96 2.03 1.95 1.71 1.74 3.05 0.15 0.46 0.457
EBIT Margin -21.22 -18.38 -23.57 -36.21 -24.00 -15.83 -5.93 -3.91 -1.76 -0.65 -0.58 -0.31 -0.29 -0.30 -0.22 -0.15 -0.09 -0.02 0.02 0.04 0.037
Asset Turnover 0.04 0.04 0.04 0.01 0.02 0.02 0.04 0.05 0.07 0.17 0.20 0.32 0.36 0.41 0.63 0.88 1.30 1.70 2.30 2.50 2.496
Equity Multiplier 5.07 1.19 1.21 1.14 1.13 1.16 1.15 1.13 1.12 1.12 1.16 1.16 1.16 1.15 1.22 1.24 1.31 1.34 1.45 1.49 1.493
Per Share
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
EPS (Diluted TTM) $-5.04 $-4.94 $-4.58 $-3.39 $-3.09 $-1.50 $-1.28 $-0.97 $-0.86 $-0.54 $-0.58 $-0.52 $-0.65 $-0.74 $-0.77 $-0.67 $-0.47 $-0.36 $-0.05 $0.04 $0.04
Book Value/Share $7.57 $12.37 $9.25 $8.25 $8.39 $4.03 $4.33 $2.96 $3.18 $2.59 $2.35 $2.23 $2.01 $1.75 $1.55 $1.63 $1.58 $1.90 $1.67 $1.81 $1.82
Tangible Book/Share $1.58 $1.72 $0.68 $0.15 $1.22 $0.43 $0.89 $0.48 $1.02 $0.79 $0.64 $0.59 $0.59 $0.45 $0.43 $0.52 $0.65 $0.87 $0.86 $1.02 $1.02
Revenue/Share $0.24 $0.27 $0.20 $0.10 $0.14 $0.09 $0.18 $0.18 $0.25 $0.45 $0.54 $0.82 $0.93 $0.97 $1.41 $1.98 $2.93 $3.97 $5.12 $6.22 $3.52
FCF/Share $-2.28 $-2.56 $-2.55 $-2.78 $-2.64 $-1.43 $-1.33 $-0.93 $-0.77 $-0.46 $-0.47 $-0.51 $-0.40 $-0.53 $-0.46 $-0.30 $-0.19 $-0.10 $-0.02 $-0.19 $-0.17
OCF/Share $-2.27 $-2.52 $-2.48 $-2.71 $-2.58 $-1.40 $-1.32 $-0.92 $-0.76 $-0.44 $-0.45 $-0.49 $-0.37 $-0.51 $-0.44 $-0.26 $-0.15 $-0.04 $0.06 $0.01 $-0.01
Cash/Share $2.44 $3.41 $2.11 $1.16 $2.01 $0.71 $1.16 $0.62 $1.07 $0.83 $0.87 $0.66 $0.70 $0.46 $0.39 $0.39 $0.47 $0.44 $0.39 $0.20 $0.20
EBITDA/Share $-4.89 $-4.78 $-4.51 $-3.27 $-2.95 $-1.23 $-0.82 $-0.47 $-0.23 $-0.13 $-0.14 $-0.08 $-0.10 $-0.14 $-0.16 $-0.16 $-0.12 $0.02 $0.24 $0.38 $0.38
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.17 $0.13 $0.10 $0.09 $0.07 $0.07 $0.06 $0.06 $0.08 $0.06 $0.05 $0.05 $0.04 $0.10 $0.28 $0.28
Net Debt/Share $-2.44 $-3.41 $-2.11 $-1.16 $-2.01 $-0.55 $-1.02 $-0.52 $-0.98 $-0.76 $-0.81 $-0.60 $-0.65 $-0.38 $-0.33 $-0.33 $-0.42 $-0.40 $-0.29 $0.08 $0.08
Academic Models
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 4 4 4 3 4 3 3 4 4 6 5 5 4 3 3 4 5 5 5 4 4
Beneish M-Score 24.01 19.83 — 5.11 -228.10 -3.26 — -3.39 0.02 3.78 -1.76 2.28 -2.22 -2.18 -0.67 -1.73 0.94 0.48 -0.23 -0.66 -0.657
Ohlson O-Score snapshot only -7.376
ROIC (Greenblatt) snapshot only 19.68%
Net-Net WC snapshot only $0.48
EVA snapshot only $-4827656.84
Credit
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Credit Rating snapshot only BBB
Credit Score 80.00 80.00 80.00 80.00 80.00 61.00 61.00 61.00 61.00 61.00 60.55 59.65 49.65 49.05 49.05 50.55 49.05 46.05 55.40 57.40 57.400
Credit Grade snapshot only 9
Credit Trend snapshot only 6.850
Implied Spread (bps) snapshot only 275.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms